Viewing Study NCT06424873



Ignite Creation Date: 2024-06-16 @ 11:48 AM
Last Modification Date: 2024-10-26 @ 3:30 PM
Study NCT ID: NCT06424873
Status: RECRUITING
Last Update Posted: 2024-05-22
First Post: 2023-11-09

Brief Title: Dynamic Whole-body PETCT Imaging in Clinical Oncology
Sponsor: Valentina Garibotto
Organization: University Hospital Geneva

Study Overview

Official Title: Dynamic Whole-body PETCT Imaging in Clinical Oncology
Status: RECRUITING
Status Verified Date: 2024-05
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: Dynamic PETCT
Brief Summary: The goal of this clinical trial is to to achieve robust quantitative whole- body parametric imaging in clinically feasible scan times in patient with oncologic pathology

The main questions it aims to answer are

question 1
question 2 Participants will describe the main tasks participants will be asked to do treatments theyll be given and use bullets if it is more than 2 items
Detailed Description: Whole body hybrid PETCT imaging making use of the standardized uptake value SUV is well established in clinical setting for diagnosis and staging treatment response monitoring and radiation therapy treatment planning of a wide range of oncologic malignancies However the SUV metric derived from static PET data does not capture the dynamics of the PET probe biodistribution in the body

The present work proposes to fill in this notable gap namely to merge whole-body and dynamic PETCT imaging to achieve robust quantitative whole- body parametric imaging in clinically feasible scan times Our proposed approach has the potential to significantly enhance diagnostic prognostic and treatment response monitoring capabilities of PETCT and to fundamentally alter routine clinical practice

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None